DRUG TODAY 润色咨询

DRUGS OF TODAY

出版年份:1998 年文章数:620 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:3.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

投稿信息

投稿信息
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%)
自引率
3.2 %
年文章数
620
期刊官网
点击查看 (点击次数:3647)
点击查看 (点击次数:1556次)
作者需知
暂无数据
偏重的研究方向
暂无数据
期刊简介
稿件收录要求

AIMS & ORGANIZATION

Drugs of Today is a peer-reviewed journal with a solid reputation of over 40 years in the scientific publications market. It is a valuable source of information on drugs introduced into the international market. Its updated monographs and articles keep the medical community abreast of the latest developments in diagnosis and treatment across therapeutic areas. This journal includes the following sections:

Monographs, up-to-date reviews on recently approved and launched drugs prepared by leading specialists after a rigorous review of the literature and from information provided by pharmaceutical companies. Updates with new relevant information or on line extensions of marketed drugs (e.g., novel formulations, new indications, etc.) are also published.

Review articles, highlighting the latest developments in the diagnosis and treatment of human diseases, as well as biomarkers for diagnosing diseases, monitoring treatment response, predicting toxicity and identifying candidates for targeted therapy.

Meeting reports, conference reports providing highlights from key congresses and symposia around the world.


SELECTION OF TOPICS TO BE REVIEWED

The Editorial Board comprises major authorities in their field who are selected to ensure that a wide variety of therapeutic areas are covered. The Board members recommend reviews from authorities within their field to guarantee that all topics are covered comprehensively and that all issues of current importance are emphasized. Submitted articles are peer reviewed before publication.

Supplementary issues devoted to recently marketed drugs and symposia proceedings are periodically published. Supplements are written by leading specialists on the basis of current scientific literature and their own experience.

  • p-ISSN: 1699-3993, e-ISSN: 1699-4019 (B-47252-2009)

  • Established: 1965

  • Published: 12 issues/year and supplements

  • Reader profile: Medical specialists, clinicians, marketing & corporate strategy directors, pharmacists & pharmacologists

  • Indexed in: MEDLINE®/PubMed®, ISI® SciSearch®, BIOSIS Previews®, Current Contents® – Clinical Medicine, EMBASE, Science Citation Index Expanded™, Biological Abstracts®, Web of Science®, Journal Citation Reports® and Chemical Abstracts®